Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature

Critical Care Medicine

Volumn 25, Issue 8, 1997, Pages 1425-1430

  Sundar, Krishnamurthy ^a   Suarez, Miguel ^a   Banogon, Petra E ^a   Shapiro, Janet M ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Fatty liver; Hepatic failure; Lactic acidosis; Mitochondrial myopathy; Zidovudine

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANOREXIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COUGHING; DOSE RESPONSE; FATIGUE; FATTY LIVER; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; LACTIC ACIDOSIS; LIVER FAILURE; MALAISE; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING;

ACIDOSIS, LACTIC; ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; FATAL OUTCOME; FATTY LIVER; FEMALE; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; ZIDOVUDINE;

EID: 0030793323     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199708000-00034     Document Type: Article

References (26)

1. Mizock BA, Falk JL: Lactic acidosis in critical illness. Crit Care Med 1992; 20: 80-93
2. Freiman JP, Helfert KE, Hamrell MR, et al: Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7:379-385
3. Fortgang IS, Belitsos PC, Chaisson RE, et al: Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol 1995; 90:1433-1436
4. Olano JP, Borucki MJ, Wen JW: Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 1995; 21:973-976
5. Lai KK, Gang DL, Zawacki JK, Cooley TP: Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddl). Ann Intern Med 1991; 115:283-284
6. Bissuel F, Bruneel F, Habersetzer F, et al: Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy (case report). J Intern Med 1994; 235:367-372
7. Stein DS: A new syndrome of hepatomegaly with severe steatosis in HIV seropositive patients. AIDS Clin Care 1994; 6:17-21
8. McKenzie R, Fried MW, Sallie R, et al: Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995; 333: 1099-1105
9. Chattha G, Arieff AI, Cummings C, et al: Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118:37-39
10. Basss NM, Ockner RK: Drug-induced liver disease. In: Hepatology: A Textbook of Liver Diseases. Zakim D, Boyer TD (Eds). Philadelphia, WB Saunders Company, 1990, pp 754-790
11. Schneiderman DJ, Arenson DM, Cello JP, et al: Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 1987; 7:925-930
12. Dhillon AP, Dusheiko GM: Pathology of hepatitis C virus infection. Histopathology 1995; 26:297-309
13. Chen C-H, Cheng Y-C: Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the antihuman immunodeficiency virus compound 2′,3′-dideoxycytidine. J Biol Chem 1989; 264:11934-11937
14. Ozawa T: Mechanism of somatic mitochondrial DNA mutations associated with age and disease. Biochim Biophys Acta 1995; 1271:177-189
15. Dalakas MC, Illa I, Pezeshkpour GH, et al: Mitochondrial myopathy caused by long-term zidovudine toxicity. N Engl J Med 1990: 322:1098-1105
16. Johns DR: Mitochondrial DNA and disease. N Engl J Med 1995; 333:638-644
17. Gopinath R, Hutcheon M, Cheema-Dhadli S, et al: Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: Biochemical studies. J Am Soc Nephrol 1992; 3:1212-1219
18. Chariot P, Monnet I, Mouchet M, et al: Determination of the blood lactate: pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum 1994; 37:583-586
19. Dalakas MC, Leon-Monzon ME, Bernardini I, et al: Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol 1994; 35: 482-487
20. Pezeshkpour G, Illa I, Dalakas MC: Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Human Pathol 1991; 22:1281-1288
21. Kruse JA, Zaidi SAJ, Carlson RW: Significance of blood lactate levels in critically ill patients with liver disease. Am J Med 1987; 83:77-82
22. Modica-Napolitano JS: AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 1993; 194:170-177
23. Barile M, Valenti D, Hobbs GA, et al: Mechanisms of toxicity of 3′-azido-3′-deoxythymidine: Its interaction with adenylate kinase. Biochem Pharmacol 1994; 48:1405-1412
24. Heinig RE, Clarke EF, Waterhouse C: Lactic acidosis and liver disease. Arch Intern Med 1979; 139:1229-1232
25. Bihari D, Gimson AES, Waterson M, et al: Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985; 13:1034-1039
26. Stacpoole PW, Wright EC, Baumgartner TG, et al: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 1992; 327:1564-1569